查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1933309

全球分子影像市場：市場規模、佔有率、成長率、產業分析、依類型、應用和地區劃分的分析、未來預測（2026-2034）

Molecular Imaging Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 180 Pages | 商品交期: 請詢問到貨日

價格

分子影像市場成長因素

受慢性病盛行率上升和先進診斷技術廣泛應用的推動，全球分子影像市場正經歷穩定成長。2025年，該市場規模為23.2億美元，預計2026年將達到24.5億美元。在預測期內，到2034年，該市場預計將達到39.2億美元，年複合成長率（CAGR）為6.05%。北美地區在2025年將以43.69%的市場佔有率領跑，這主要得益於高昂的醫療保健支出以及先進影像系統的早期應用。

分子影像技術能夠視覺化和測量細胞及分子層面的生物過程，在疾病的早期檢測、診斷和治療監測中發揮關鍵作用。正子斷層掃描（PET）和單光子發射電腦斷層掃描（SPECT）等技術已廣泛應用於腫瘤學、神經病學、心臟病學和骨科等領域。

市場驅動因素

分子影像市場的主要驅動因素是慢性病和急性病患病率的不斷上升，包括癌症、阿茲海默症、心血管疾病和神經系統疾病。根據美國國家癌症研究所預測，美國預計將新增約200萬例癌症病例，這將顯著增加對先進診斷影像技術的需求。

此外，人口老化加劇也促使診斷率上升。老年人更容易患慢性疾病，這推動了分子影像技術的應用。人們對疾病早期檢測意識的提高以及影像精度的不斷提升也進一步推動了市場成長。

市場限制與挑戰

儘管市場穩定成長，但分子影像設備的高昂成本仍是市場面臨的一大挑戰。 PET/CT掃描儀的價格在50萬美元到500萬美元之間，這限制了其普及，尤其是在中低收入國家。

另一個主要挑戰是翻新影像設備監管市場的出現。翻新PET/CT掃描儀的價格遠低於新系統，在新興經濟體中越來越受歡迎。這種價格差異抑制了新設備的銷售，並影響了製造商的收入成長。

市場機會與趨勢

分子影像在醫學領域的應用範圍不斷擴大，為其帶來了強勁的成長機會。它正日益用於評估治療效果、指導個人化醫療以及即時檢測。更快的影像擷取流程和更高的影像品質進一步推動了其在臨床環境中的應用。

市場的一個顯著趨勢是向技術先進的混合成像系統（例如PET/CT和SPECT/CT）的轉變。這些系統具有更高的解析度、更短的掃描時間和更高的診斷準確性。監管機構的批准以及主要製造商的持續創新加速從傳統成像技術向混合成像技術的過渡。

細分市場洞察

依類型劃分，正子斷層掃描（PET）佔據了最大的市場佔有率，這主要得益於神經系統疾病盛行率的上升以及每百萬人口中PET掃描儀安裝數量的增加。由於研發投入的增加，SPECT領域也預計將穩定成長。

依應用領域劃分，腫瘤學領域因癌症診斷率的提高而成為市場成長的主要驅動力。由於損傷率和神經系統疾病的增加，骨科和神經系統疾病領域預計將以顯著的年複合成長率成長。

依終端用戶劃分，診斷影像中心預計將快速成長，這得益於患者就醫便利性的提高、等待時間的縮短以及獨立影像診斷機構的興起。

區域分析

到2025年，北美地區的市場收入達到10.1億美元，主要得益於先進的醫療基礎設施和有利的償付政策。歐洲市場持續成長，這主要得益於診斷影像設備安裝量的增加以及政府支持的研究計畫。亞太地區預計將成為成長最快的地區，這主要得益於龐大的患者群體、人口老化以及中國、日本和印度等國家不斷擴大的醫療基礎設施。

目錄

第1章 引言

第2章 執行摘要

第3章 市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機會
  • 市場趨勢

第4章 主要考察

  • 主要國家/地區主要疾病盛行率（2024/2025）
  • 分子影像設備的技術進步
  • 主要國家安裝量（2024/2025）
  • 主要公司新產品發布
  • 關鍵趨勢：併購併購與業務合作
  • 新冠疫情對市場的影響

第5章 全球分子影像市場分析：洞察與預測（2021-2034）

  • 市場分析、洞察與預測：依類型劃分
    • 正子斷層掃描（PET）
    • 單光子發射電腦斷層掃描（SPECT）
    • 其他
  • 市場分析、洞察與預測：依應用劃分
    • 心臟疾病
    • 腫瘤
    • 骨科
    • 婦科
    • 神經系統疾病
    • 其他
  • 市場分析、洞察與預測：依最終用戶劃分
    • 醫院
    • 專科診所
    • 診斷影像中心
    • 其他
  • 市場分析、洞察與預測：依地區劃分
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第6章 北美分子影像市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 美國
    • 加拿大

第7章 歐洲分子影像市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 斯堪的納維亞
    • 歐洲其他地區

第8章 亞太分子影像市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 日本
    • 澳洲
    • 中國
    • 印度
    • 東南亞
    • 亞太其他地區

第9章 拉丁美洲分子影像市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區美國

第10章 中東與非洲分子影像市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • GCC國家
    • 南非
    • 中東和非洲其他地區

第11章 競爭分析

  • 全球市場佔有率分析（2025）
  • 公司簡介
    • GE Healthcare
    • Siemens Healthineers AG
    • Koninklijke Philips N.V.
    • Shimadzu Corporation
    • CANON MEDICAL SYSTEMS CORPORATION
    • Bruker
    • Lantheus Holdings, Inc.
    • Segami Corporation
Product Code: FBI112879

Growth Factors of molecular imaging Market

The global molecular imaging market is witnessing consistent growth driven by rising prevalence of chronic diseases and increasing adoption of advanced diagnostic technologies. In 2025, the market was valued at USD 2.32 billion and is projected to grow to USD 2.45 billion in 2026. Over the forecast period, the market is expected to reach USD 3.92 billion by 2034, expanding at a CAGR of 6.05%. North America dominated the market with a 43.69% share in 2025, supported by high healthcare expenditure and early adoption of advanced imaging systems.

Molecular imaging enables visualization and measurement of biological processes at the cellular and molecular levels, playing a crucial role in early disease detection, diagnosis, and treatment monitoring. Technologies such as positron emission tomography (PET) and single photon emission computed tomography (SPECT) are widely used across oncology, neurology, cardiology, and orthopedics.

Market Drivers

The primary driver of the molecular imaging market is the increasing prevalence of chronic and acute disorders, including cancer, Alzheimer's disease, cardiovascular diseases, and neurological conditions. According to the National Cancer Institute, nearly 2.0 million new cancer cases were expected to be diagnosed in the U.S., significantly increasing demand for advanced diagnostic imaging.

Additionally, the growing geriatric population is contributing to higher diagnosis rates. Aging populations are more susceptible to chronic conditions, thereby boosting the utilization of molecular imaging techniques. Rising awareness about early disease detection and continuous improvements in imaging accuracy further support market growth.

Market Restraints and Challenges

Despite steady growth, the market faces challenges due to the high cost of molecular imaging equipment. PET/CT scanners can cost between USD 0.5 million and USD 5.0 million, limiting adoption, particularly in low- and middle-income countries.

Another major challenge is the emergence of a regulated market for refurbished imaging devices. Refurbished PET/CT scanners, priced significantly lower than new systems, are gaining traction in emerging economies. This price gap is restraining new equipment sales and impacting revenue growth for manufacturers.

Market Opportunities and Trends

The expanding range of medical applications for molecular imaging presents strong growth opportunities. Molecular imaging is increasingly used to assess treatment response, guide personalized medicine, and enable point-of-care testing. Faster imaging procedures and improved image quality have further enhanced clinical adoption.

A prominent trend in the market is the shift toward technologically advanced hybrid imaging systems, such as PET/CT and SPECT/CT. These systems offer superior resolution, reduced scan times, and enhanced diagnostic accuracy. Regulatory approvals and continuous innovation by leading manufacturers are accelerating the transition from conventional to hybrid imaging technologies.

Segmentation Insights

By type, Positron Emission Tomography (PET) held the largest market share, driven by rising neurological disorder prevalence and increasing installed scanner bases per million population. The SPECT segment is also expected to grow steadily due to rising R&D investments.

By application, oncology dominated the market, owing to increasing cancer diagnosis rates. Orthopedics and neurology are anticipated to grow at notable CAGRs due to rising injury rates and neurological disorders.

By end-user, diagnostic imaging centers are expected to grow rapidly, supported by patient convenience, reduced waiting times, and the growing number of independent imaging facilities.

Regional Analysis

North America generated USD 1.01 billion in revenue in 2025, driven by advanced healthcare infrastructure and favorable reimbursement policies. Europe continues to grow due to increasing installed imaging bases and government-backed research initiatives. Asia Pacific is projected to be the fastest-growing region, supported by a large patient pool, aging population, and expanding healthcare infrastructure in countries such as China, Japan, and India.

Competitive Landscape

The molecular imaging market is consolidated, with key players such as GE Healthcare, Siemens Healthineers AG, and Koninklijke Philips N.V. dominating global market share. These companies focus on innovation, product launches, and strategic collaborations to strengthen their market presence.

Conclusion

The global molecular imaging market is poised for steady growth, expanding from USD 2.32 billion in 2025 to USD 3.92 billion by 2034. Rising prevalence of chronic diseases, increasing adoption of hybrid imaging technologies, and advancements in personalized medicine are key growth drivers. While high equipment costs and refurbished device markets pose challenges, continuous innovation and expanding clinical applications will ensure sustained market expansion throughout the forecast period.

Segmentation By Type

  • Positron Emission Tomography (PET)
  • Single Photon Emission Computed Tomography (SPECT)
  • Others

By Application

  • Cardiology
  • Oncology
  • Orthopedics
  • Gynecology
  • Neurology
  • Others

By End-user

  • Hospitals
  • Specialty Clinics
  • Diagnostic Imaging Centers
  • Others

By Geography

  • North America (By Type, Application, End-user, and Country)
    • U.S.
    • Canada
  • Europe (By Type, Application, End-user, and Country/Sub-region)
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Type, Application, End-user, and Country/Sub-region)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Type, Application, End-user, and Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Type, Application, End-user, and Country/Sub-region)
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Key Disorders, Key Countries/Regions, 2024/2025
  • 4.2. Technological Advancements in Molecular Imaging Equipment
  • 4.3. Installed Base, Key Countries/Regions, 2024/2025
  • 4.4. New Product Launches, Key Players
  • 4.5. Key Industry Developments - Mergers, Acquisitions & Partnerships
  • 4.6. Impact of COVID-19 on the Market

5. Global Molecular Imaging Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Type
    • 5.1.1. Positron Emission Tomography (PET)
    • 5.1.2. Single-Photon Emission Computed Tomography (SPECT)
    • 5.1.3. Others
  • 5.2. Market Analysis, Insights and Forecast - By Application
    • 5.2.1. Cardiology
    • 5.2.2. Oncology
    • 5.2.3. Orthopedics
    • 5.2.4. Gynecology
    • 5.2.5. Neurology
    • 5.2.6. Others
  • 5.3. Market Analysis, Insights and Forecast - By End User
    • 5.3.1. Hospitals
    • 5.3.2. Specialty Clinics
    • 5.3.3. Diagnostic Imaging Centers
    • 5.3.4. Others
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Molecular Imaging Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Type
    • 6.1.1. Positron Emission Tomography (PET)
    • 6.1.2. Single-Photon Emission Computed Tomography (SPECT)
    • 6.1.3. Others
  • 6.2. Market Analysis, Insights and Forecast - By Application
    • 6.2.1. Cardiology
    • 6.2.2. Oncology
    • 6.2.3. Orthopedics
    • 6.2.4. Gynecology
    • 6.2.5. Neurology
    • 6.2.6. Others
  • 6.3. Market Analysis, Insights and Forecast - By End User
    • 6.3.1. Hospitals
    • 6.3.2. Specialty Clinics
    • 6.3.3. Diagnostic Imaging Centers
    • 6.3.4. Others
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe Molecular Imaging Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Type
    • 7.1.1. Positron Emission Tomography (PET)
    • 7.1.2. Single-Photon Emission Computed Tomography (SPECT)
    • 7.1.3. Others
  • 7.2. Market Analysis, Insights and Forecast - By Application
    • 7.2.1. Cardiology
    • 7.2.2. Oncology
    • 7.2.3. Orthopedics
    • 7.2.4. Gynecology
    • 7.2.5. Neurology
    • 7.2.6. Others
  • 7.3. Market Analysis, Insights and Forecast - By End User
    • 7.3.1. Hospitals
    • 7.3.2. Specialty Clinics
    • 7.3.3. Diagnostic Imaging Centers
    • 7.3.4. Others
  • 7.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.4.1. U.K.
    • 7.4.2. Germany
    • 7.4.3. France
    • 7.4.4. Spain
    • 7.4.5. Italy
    • 7.4.6. Scandinavia
    • 7.4.7. Rest of Europe

8. Asia pacific Molecular Imaging Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Type
    • 8.1.1. Positron Emission Tomography (PET)
    • 8.1.2. Single-Photon Emission Computed Tomography (SPECT)
    • 8.1.3. Others
  • 8.2. Market Analysis, Insights and Forecast - By Application
    • 8.2.1. Cardiology
    • 8.2.2. Oncology
    • 8.2.3. Orthopedics
    • 8.2.4. Gynecology
    • 8.2.5. Neurology
    • 8.2.6. Others
  • 8.3. Market Analysis, Insights and Forecast - By End User
    • 8.3.1. Hospitals
    • 8.3.2. Specialty Clinics
    • 8.3.3. Diagnostic Imaging Centers
    • 8.3.4. Others
  • 8.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.4.1. Japan
    • 8.4.2. Australia
    • 8.4.3. China
    • 8.4.4. India
    • 8.4.5. Southeast Asia
    • 8.4.6. Rest of Asia Pacific

9. Latin America Molecular Imaging Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Type
    • 9.1.1. Positron Emission Tomography (PET)
    • 9.1.2. Single-Photon Emission Computed Tomography (SPECT)
    • 9.1.3. Others
  • 9.2. Market Analysis, Insights and Forecast - By Application
    • 9.2.1. Cardiology
    • 9.2.2. Oncology
    • 9.2.3. Orthopedics
    • 9.2.4. Gynecology
    • 9.2.5. Neurology
    • 9.2.6. Others
  • 9.3. Market Analysis, Insights and Forecast - By End User
    • 9.3.1. Hospitals
    • 9.3.2. Specialty Clinics
    • 9.3.3. Diagnostic Imaging Centers
    • 9.3.4. Others
  • 9.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America

10. Middle East & Africa Molecular Imaging Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Type
    • 10.1.1. Positron Emission Tomography (PET)
    • 10.1.2. Single-Photon Emission Computed Tomography (SPECT)
    • 10.1.3. Others
  • 10.2. Market Analysis, Insights and Forecast - By Application
    • 10.2.1. Cardiology
    • 10.2.2. Oncology
    • 10.2.3. Orthopedics
    • 10.2.4. Gynecology
    • 10.2.5. Neurology
    • 10.2.6. Others
  • 10.3. Market Analysis, Insights and Forecast - By End User
    • 10.3.1. Hospitals
    • 10.3.2. Specialty Clinics
    • 10.3.3. Diagnostic Imaging Centers
    • 10.3.4. Others
  • 10.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.4.1. GCC
    • 10.4.2. South Africa
    • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. GE Healthcare
      • 11.2.1.1. Overview
      • 11.2.1.2. Products
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. Siemens Healthineers AG
      • 11.2.2.1. Overview
      • 11.2.2.2. Products
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Koninklijke Philips N.V.
      • 11.2.3.1. Overview
      • 11.2.3.2. Products
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. Shimadzu Corporation
      • 11.2.4.1. Overview
      • 11.2.4.2. Products
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. CANON MEDICAL SYSTEMS CORPORATION
      • 11.2.5.1. Overview
      • 11.2.5.2. Products
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. Bruker
      • 11.2.6.1. Overview
      • 11.2.6.2. Products
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. Lantheus Holdings, Inc.
      • 11.2.7.1. Overview
      • 11.2.7.2. Products
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Segami Corporation
      • 11.2.8.1. Overview
      • 11.2.8.2. Products
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Molecular Imaging Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 2: Global Molecular Imaging Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 3: Global Molecular Imaging Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 4: Global Molecular Imaging Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 5: North America Molecular Imaging Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 6: North America Molecular Imaging Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 7: North America Molecular Imaging Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 8: North America Molecular Imaging Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 9: Europe Molecular Imaging Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 10: Europe Molecular Imaging Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 11: Europe Molecular Imaging Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 12: Europe Molecular Imaging Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 13: Asia Pacific Molecular Imaging Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 14: Asia Pacific Molecular Imaging Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 15: Asia Pacific Molecular Imaging Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 16: Asia Pacific Molecular Imaging Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 17: Latin America Molecular Imaging Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 18: Latin America Molecular Imaging Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 19: Latin America Molecular Imaging Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 20: Latin America Molecular Imaging Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 21: Middle East & Africa Molecular Imaging Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 22: Middle East & Africa Molecular Imaging Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 23: Middle East & Africa Molecular Imaging Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 24: Middle East & Africa Molecular Imaging Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Molecular Imaging Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Molecular Imaging Market Value Share (%), by Type, 2025 & 2034
  • Figure 3: Global Molecular Imaging Market Value Share (%), by Application, 2025 & 2034
  • Figure 4: Global Molecular Imaging Market Value Share (%), by End User, 2025 & 2034
  • Figure 5: Global Molecular Imaging Market Value Share (%), by Region, 2025 & 2034
  • Figure 6: North America Molecular Imaging Market Value (USD billion), by Type, 2025 & 2034
  • Figure 7: North America Molecular Imaging Market Value Share (%), by Type, 2025
  • Figure 8: North America Molecular Imaging Market Value (USD billion), by Application, 2025 & 2034
  • Figure 9: North America Molecular Imaging Market Value Share (%), by Application, 2025
  • Figure 10: North America Molecular Imaging Market Value (USD billion), by End User, 2025 & 2034
  • Figure 11: North America Molecular Imaging Market Value Share (%), by End User, 2025
  • Figure 12: North America Molecular Imaging Market Value (USD billion), By Country, 2025 & 2034
  • Figure 13: North America Molecular Imaging Market Value Share (%), By Country, 2025
  • Figure 14: Europe Molecular Imaging Market Value (USD billion), by Type, 2025 & 2034
  • Figure 15: Europe Molecular Imaging Market Value Share (%), by Type, 2025
  • Figure 16: Europe Molecular Imaging Market Value (USD billion), by Application, 2025 & 2034
  • Figure 17: Europe Molecular Imaging Market Value Share (%), by Application, 2025
  • Figure 18: Europe Molecular Imaging Market Value (USD billion), by End User, 2025 & 2034
  • Figure 19: Europe Molecular Imaging Market Value Share (%), by End User, 2025
  • Figure 20: Europe Molecular Imaging Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 21: Europe Molecular Imaging Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 22: Asia Pacific Molecular Imaging Market Value (USD billion), by Type, 2025 & 2034
  • Figure 23: Asia Pacific Molecular Imaging Market Value Share (%), by Type, 2025
  • Figure 24: Asia Pacific Molecular Imaging Market Value (USD billion), by Application, 2025 & 2034
  • Figure 25: Asia Pacific Molecular Imaging Market Value Share (%), by Application, 2025
  • Figure 26: Asia Pacific Molecular Imaging Market Value (USD billion), by End User, 2025 & 2034
  • Figure 27: Asia Pacific Molecular Imaging Market Value Share (%), by End User, 2025
  • Figure 28: Asia Pacific Molecular Imaging Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 29: Asia Pacific Molecular Imaging Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 30: Latin America Molecular Imaging Market Value (USD billion), by Type, 2025 & 2034
  • Figure 31: Latin America Molecular Imaging Market Value Share (%), by Type, 2025
  • Figure 32: Latin America Molecular Imaging Market Value (USD billion), by Application, 2025 & 2034
  • Figure 33: Latin America Molecular Imaging Market Value Share (%), by Application, 2025
  • Figure 34: Latin America Molecular Imaging Market Value (USD billion), by End User, 2025 & 2034
  • Figure 35: Latin America Molecular Imaging Market Value Share (%), by End User, 2025
  • Figure 36: Latin America Molecular Imaging Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 37: Latin America Molecular Imaging Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 38: Middle East & Africa Molecular Imaging Market Value (USD billion), by Type, 2025 & 2034
  • Figure 39: Middle East & Africa Molecular Imaging Market Value Share (%), by Type, 2025
  • Figure 40: Middle East & Africa Molecular Imaging Market Value (USD billion), by Application, 2025 & 2034
  • Figure 41: Middle East & Africa Molecular Imaging Market Value Share (%), by Application, 2025
  • Figure 42: Middle East & Africa Molecular Imaging Market Value (USD billion), by End User, 2025 & 2034
  • Figure 43: Middle East & Africa Molecular Imaging Market Value Share (%), by End User, 2025
  • Figure 44: Middle East & Africa Molecular Imaging Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 45: Middle East & Africa Molecular Imaging Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 46: Global Molecular Imaging Market Share (%), By Company, 2025